Job Research Foundation Awards 2025 Grant to Innovative Research on Job Syndrome

Job Research Foundation Advances Job Syndrome Research in 2025

The Job Research Foundation has taken a significant step forward in the fight against Job Syndrome, a rare multisystem immunodeficiency disorder also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES). Established to promote research in this field, the Foundation's mission is to enhance treatment options and ultimately discover a cure for this challenging condition.

On February 25, 2025, the Foundation announced that Dr. Beate Hagl and Dr. Carola Voss, both highly regarded researchers from Helmholtz Munich's Institute of Lung Health and Immunization in Germany, have been awarded a two-year grant totaling $200,000. Their research project, titled "Novel Strategies for the Prevention and Treatment of Lung Disease in Job Syndrome Patients," aims to explore effective treatment methods to alleviate the lung complications that often arise in patients afflicted with Job Syndrome.

This latest grant marks another milestone for the Job Research Foundation, which has funded a total of 16 research initiatives since its inception in 2019. The scientists who have benefited from the Foundation's financial support hail from diverse countries, including Australia, Germany, Spain, the US, the UK, and Denmark. They are based at prestigious institutions such as the Garvan Institute, the Helmholtz Zentrum München, and Massachusetts General/Harvard Medical School among others.

Job Syndrome, discovered over fifty years ago in 1966, is characterized by heightened immunologic responses and predispositions to infections and lung disease, affecting both males and females globally. The relentless pursuit of understanding this complex disorder continues to drive the Foundation’s objectives.

The Job Research Foundation is committed to supporting innovative research that addresses the challenges faced by Job Syndrome patients. It invites further grant applications starting in July 2025, widening the opportunity for researchers worldwide to contribute to new insights and breakthroughs.

For more information about the Job Research Foundation, the ongoing research projects, and application details, please visit their official website. Additional resources can within the Foundation's platform illustrate the ongoing advancements in research efforts and a list of the researchers and their projects.

As the Foundation looks ahead, it remains focused on overcoming the barriers presented by this rare disease and hopes to achieve significant milestones in treatment development through collaborative research efforts. The journey toward a comprehensive understanding of Job Syndrome continues, and with each funded project, the Foundation takes a step closer to realizing its goal of improved care and potentially a cure.

For media inquiries, you can reach out to Risa B. Hoag at GMG PR via phone or email.

Stay tuned as we continue to cover developments in the fight against Job Syndrome and more breakthroughs in health research.

Media Contact:
Risa B. Hoag
GMG PR
Phone: 845-627-3000
Email: [email protected]